|
2023-02-27 |
2022-11-28 |
V
Verkauf
|
HEALY JAMES
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
6.000
-100.0%
14,32
85.920
USD
|
6.000
-100.0%
|
14,32
|
85.920
USD
|
|
|
2022-08-17 |
2022-08-15 |
K
Kauf
|
5AM Partners VI, LLC
Large shareholder
|
487.333
+inf%
30,00
14.619.990
USD
|
487.333
+inf%
|
30,00
|
14.619.990
USD
|
|
|
2022-08-17 |
2022-08-15 |
K
Kauf
|
5AM Partners VI, LLC
Large shareholder
|
112.667
+2.9%
30,00
3.380.010
USD
|
112.667
+2.9%
|
30,00
|
3.380.010
USD
|
|
|
2022-08-17 |
2022-08-15 |
K
Kauf
|
Sofinnova Partners SAS
Large shareholder
|
133.333
+3.3%
30,00
3.999.990
USD
|
133.333
+3.3%
|
30,00
|
3.999.990
USD
|
|
|
2022-08-15 |
2022-08-11 |
K
Kauf
|
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.
Large shareholder
|
83.000
+2.0%
30,00
2.490.000
USD
|
83.000
+2.0%
|
30,00
|
2.490.000
USD
|
|
|
2022-08-15 |
2022-08-11 |
K
Kauf
|
Sofinnova Venture Partners X, L.P.
Large shareholder
|
500.000
+9.0%
30,00
15.000.000
USD
|
500.000
+9.0%
|
30,00
|
15.000.000
USD
|
|
|
2022-08-15 |
2022-08-11 |
K
Kauf
|
GENERAL ATLANTIC, L.P.
Large shareholder
|
83.000
+2.0%
30,00
2.490.000
USD
|
83.000
+2.0%
|
30,00
|
2.490.000
USD
|
|
|
2022-08-15 |
2022-08-11 |
K
Kauf
|
HEALY JAMES
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
6.000
+inf%
30,00
180.000
USD
|
6.000
+inf%
|
30,00
|
180.000
USD
|
|
|
2022-08-15 |
2022-08-11 |
K
Kauf
|
HEALY JAMES
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
500.000
+9.0%
30,00
15.000.000
USD
|
500.000
+9.0%
|
30,00
|
15.000.000
USD
|
|
|
2023-02-27 |
2022-06-10 |
V
Verkauf
|
Freeman Mason
Chief Medical Officer
Führungsperson
|
6
-0.2%
15,21
91
USD
|
6
-0.2%
|
15,21
|
91
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
Coelho Mary Theresa
EVP CFO & Chief BD Officer
Führungsperson
|
100
+inf%
16,00
1.600
USD
|
100
+inf%
|
16,00
|
1.600
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
Sofinnova Venture Partners X, L.P.
Large shareholder
|
325.000
+6.2%
16,00
5.200.000
USD
|
325.000
+6.2%
|
16,00
|
5.200.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
HEALY JAMES
Nicht geschäftsführender Verwaltungsratsmitglied
Large shareholder
|
325.000
+6.2%
16,00
5.200.000
USD
|
325.000
+6.2%
|
16,00
|
5.200.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
Sofinnova Partners SAS
Large shareholder
|
220.000
+5.7%
16,00
3.520.000
USD
|
220.000
+5.7%
|
16,00
|
3.520.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
5AM Partners VI, LLC
Large shareholder
|
312.500
+170.0%
16,00
5.000.000
USD
|
312.500
+170.0%
|
16,00
|
5.000.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
5AM Partners VI, LLC
Large shareholder
|
157.500
+4.3%
16,00
2.520.000
USD
|
157.500
+4.3%
|
16,00
|
2.520.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
GENERAL ATLANTIC GENPAR (BERMUDA), L.P.
Large shareholder
|
1.700.000
+70.1%
16,00
27.200.000
USD
|
1.700.000
+70.1%
|
16,00
|
27.200.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
de Garidel Marc
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
12.500
+inf%
16,00
200.000
USD
|
12.500
+inf%
|
16,00
|
200.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
Pearce Catherine
Chief Operating Officer
Führungsperson
|
1.500
+inf%
16,00
24.000
USD
|
1.500
+inf%
|
16,00
|
24.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
Pearce Catherine
Chief Operating Officer
Führungsperson
|
750
+0.6%
16,00
12.000
USD
|
750
+0.6%
|
16,00
|
12.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
Freeman Mason
EVP Clinical Development
Führungsperson
|
100
+inf%
16,00
1.600
USD
|
100
+inf%
|
16,00
|
1.600
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
Freeman Mason
EVP Clinical Development
Führungsperson
|
2.500
+inf%
16,00
40.000
USD
|
2.500
+inf%
|
16,00
|
40.000
USD
|
|
|
2022-01-13 |
2022-01-11 |
K
Kauf
|
GENERAL ATLANTIC, L.P.
Large shareholder
|
1.700.000
+70.1%
16,00
27.200.000
USD
|
1.700.000
+70.1%
|
16,00
|
27.200.000
USD
|
|
